Does social capital affect mental health, quality of life and disease control in diabetes patients from Côte d’Ivoire?
- Conditions
- Improving glycemic control and quality of life in patients with type 2 diabetes (T2D)Nutritional, Metabolic, EndocrineType 2 diabetes mellitus
- Registration Number
- ISRCTN10901121
- Lead Sponsor
- Swiss Tropical and Public Health Institute
- Brief Summary
2024 Protocol article in https://doi.org/10.1136/bmjopen-2022-069934 (added 11/01/2024)
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Ongoing
- Sex
- All
- Target Recruitment
- 1000
1. Having a T2D diagnosed within the 3 months period prior INSP first visit
2. Receiving first prescription of antidiabetic drug from INSP
3. Aged 18 years or older and living in the city of Abidjan
4. Having no plan to move from home for the following 12 months
5. Living with family member or someone in the household
6. Access to a telephone
1. Severely ill patients requiring hospitalization at first visit
2. Diagnoses of other illnesses not suitable with the study (cancer, severe psychiatric disease/dementia, asthma, spinal cord injury, congestive heart failure)
3. Pregnant or preparing for pregnancy (women only)
4. Unwilling to provide informed consent
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method HbA1c measured using blood test 3 and 12 months
- Secondary Outcome Measures
Name Time Method 1. HbA1c at baseline, 3 and 12 months<br>2. Hypoglycemia event profile measured using patient (self-tests) and hospital records after 3 and 12 months<br>3. Quality of life measured using Depression, Anxiety and Stress Scale-21 (DASS-21) at baseline, 3 and 12 months<br>4. Mental health status (depression, anxiety and stress) measured using WHO Quality of Life (WHOQOL-BREF) Questionnaire at baseline, 3 and 12 months